Katherine Fening, MD
Dermatopathology · Mayfield Heights, OHNPI 1992017230
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,916 of the $10,178 with a category attached, or 87.6%. 41 manufacturers reported payments, led by AbbVie at 34.0% of the total. Reporting peaked in 2019 at $2,688 and has fallen 73.1% since, to $724 in 2025.
Across 422 payments — averaging $24.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$715
- LEO Pharma Inc.$614
- Novartis$535
- Galderma Laboratories, L.p.$520
- Incyte Corporation$365
- plus $4K from 35 others
What the payments were for
- Consulting fees$1,00010%
- Travel & lodging$1071%
- Food & beverage$8,91688%
- Education$1552%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,178 in reported general payments places this provider in the 85th percentile of 25 dermatopathology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 21 | $77,716 |
| Clindamycin Phosphate | 36 | $1,865 |
| Desonide | 27 | $1,677 |
| Ketoconazole | 53 | $1,304 |
| Betamethasone Dipropionate | 11 | $541 |
| Doxycycline Hyclate | 23 | $493 |
| Triamcinolone Acetonide | 21 | $305 |
| Mupirocin | 30 | $229 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Mayfield Heights
- Caroline WinslowMayfield Heights$320
- Melissa PiliangCleveland$123K
- Neera Agarwal AntalHudson$39K
- Adam HesselDublin$11K
- Lindsey DohseChillicothe$7K
- Omar SalemSylvania$5K
- Joshua WeaverAkron$3K
- Janet WieselthierLyndhurst$3K
- Stephen SomachCleveland$3K
- Kimberly HollandsworthCleveland$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.